Comments

Denali Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Denali Therapeutics (DNLI) operate in?

Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DNLINASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$12.50

-0.36-2.80%

At close: -

$12.50

0.000.00%

After Hours: 4:00 PM EDT

Denali Therapeutics (DNLI) Forecast

News Earnings Denali Therapeutics (DNLI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Denali Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DNLI | Benzinga

Explore Denali Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DNLI.

Open	$12.86
Close	$12.50
Volume / Avg.	1.34M / 1.25M
Day Range	$12.00 - $12.97
52 Wk Range	10.57 - 33.33
Market Cap	$1.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	9.31%
Days to Cover	10.25

Recent News

What Happened To Denali Therapeutics Stock Wednesday?

Denali Therapeutics, Inc. (NASDAQ:DNLI) shares traded higher on Wednesday after the company initiated its biologics license application (BLA) for the accelerated approval of Tividenofusp Alfa for the treatment of Hunter syndrome.

Dylan Berman

Denali Therapeutics Ends ALS Trial Extension, Analyst Stays Optimistic Despite Trial Setback

Denali Therapeutics' ALS drug DNL343 failed to show efficacy, leading to the discontinuation of the trial extension. Analysts now focus on its Hunter syndrome drug.

Vandana Singh

Why Is Denali Therapeutics Stock Trading Higher On Wednesday?

Denali Therapeutics showcases its BBB platform at J.P. Morgan Conference, highlighting DNL310's Hunter syndrome progress and plans for commercialization.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$12.86
Close	$12.50
Volume / Avg.	1.34M / 1.25M
Day Range	$12.00 - $12.97
52 Wk Range	10.57 - 33.33
Market Cap	$1.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	9.31%
Days to Cover	10.25

About Denali Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering the...

Got Questions? Ask

How has DNLI's EPS changed?

How is DNLI's revenue growing?

What is DNLI's average daily volume?

What is DNLI's current ratio?

What is DNLI's Sharpe ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Denali Therapeutics (DNLI) stock?

You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.

View our list of the best stock brokerages

Who are Denali Therapeutics (DNLI) competitors?

Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Ascentage Pharma Group (NASDAQ:AAPG).

What is the forecast, or price target, for Denali Therapeutics (DNLI) stock?

Denali Therapeutics has a consensus price target of $38.79.

What is the current price for Denali Therapeutics (DNLI)?

The stock price for Denali Therapeutics (NASDAQ: DNLI) is $12.5 last updated April 10, 2025 at 4:00 PM EDT.

Does Denali Therapeutics (DNLI) pay a dividend?

There are no upcoming dividends for Denali Therapeutics.

When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?

Denali Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Denali Therapeutics (DNLI) going to split?

There is no upcoming split for Denali Therapeutics.

What sector and industry does Denali Therapeutics (DNLI) operate in?

Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.